Godrej Agrovet Limited has informed the Exchange regarding Forfeiture/Cancellation of 7518 Options.
GODREJAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godrej Agrovet's Board approved audited financial results for Q4 and FY ending March 31, 2026, with an unmodified auditor opinion. Consolidated revenue from operations rose to Rs. 10,232.68 crore in FY26 from Rs. 9,382.77 crore in FY25 (about 9% growth), while consolidated net profit grew to Rs. 445.18 crore from Rs. 403.37 crore (about 10% growth). Q4 FY26 consolidated profit jumped to Rs. 102.28 crore versus Rs. 66.10 crore a year ago, aided by a Rs. 33.48 crore profit on sale of land in the Animal Nutrition segment. Standalone FY26 profit was Rs. 526.26 crore, weighed by a Rs. 32.96 crore impairment in subsidiary Godrej Cattle Genetics. The Board recommended a final dividend of Rs. 11 per share (110% on face value) subject to shareholder approval, with the AGM set for August 5, 2026. The company also allotted 30,973 shares under ESGS 2018, noted the lapse of 7,518 stock options (as per the headline), and granted 50,507 new options to employees at Rs. 10 per option.
Annual results show steady mid-single-digit revenue growth and double-digit profit growth, with a healthy dividend payout that should appeal to income-focused investors. The Q4 profit surge driven by a one-time land sale gain may not be fully recurring, but core business trends remain positive, likely a mildly positive signal for the stock.